Rogue-RX on-site generation using electronics

Active Other Transaction Agreement Awarded Last action

Contract number
140D042490003
Awardee
Awarding agency
Obligated
$18,989,775

Award facts

Contract value 54% obligated
  • $18,989,775.00 Current, with exercised options
  • $34,866,053.00 Potential, with all options
Completion date 35% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Institutes of Health Department of Health and Human Services
NAICS code
Not on record
Competition
Competed Program Solicitation
Pricing
Other
Place of performance
Pittsburgh, PA 15213, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $18,989,775

About this award

Carnegie Mellon University was awarded an Other Transaction Agreement (OTA) valued at $34.87 million by the National Institutes of Health for the ROGUE-RX (Rogue: RX On-Site Generation Using Electronics) program. The contract, effective through September 15, 2030, supports research and development activities at Carnegie Mellon's Pittsburgh, Pennsylvania facility, leveraging the university's multidisciplinary expertise in advanced engineering, computational modeling, and biotechnology. As a non-set-aside award, this OTA was competitively selected based on technical merit and reflects NIH's confidence in Carnegie Mellon's research capabilities across life sciences and emerging biotechnology applications.

This award builds upon Carnegie Mellon's established track record of delivering federal research contracts and grants across defense and civilian agencies. The university has previously executed substantial contracts and cooperative agreements with NIH and affiliated institutes, including a $18.054 million cooperative agreement for 3D bioprinted liver tissue development and multiple grants supporting biomedical research. The OTA structure provides NIH with flexible acquisition mechanisms outside traditional contracting frameworks, enabling rapid iteration and advancement of innovative research priorities aligned with the institute's mission in advancing biomedical science and health-related technologies.

Subawards

Subcontractor Amount Awarded
William Marsh Rice University ROGUE-RX ON-SITE GENERATION USING ELECTRONICS ARPA-H: ROGUE - Rx On-site Generation Using Electronics $1,280,358
Georgia TECH Research Corp ROGUE-RX ON-SITE GENERATION USING ELECTRONICS ROGUE pioneers the co-design of modern integrated circuits and wearables with synthetic biological circuitry… $953,376
William Marsh Rice University ROGUE-RX ON-SITE GENERATION USING ELECTRONICS ARPA-H: ROGUE - Rx On-site Generation Using Electronics $1,276,322

Quick answers

Who was awarded contract 140D042490003?

140D042490003 was awarded to Carnegie-Mellon University by Interior Business Center (Office of Policy Management and Budget) on September 16, 2024.

How much is contract 140D042490003 worth?

The government has obligated $18,989,775 on 140D042490003. Its potential value, with all options, is $34,866,053.

Which agency awarded contract 140D042490003?

Interior Business Center (Office of Policy Management and Budget) awarded 140D042490003, with funding from National Institutes of Health (Department of Health and Human Services).

Was contract 140D042490003 competed?

The extent of competition for 140D042490003 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award